Molecular BiologyGastroenterologyPeer-reviewed
IL-11 neutralising therapies target hepatic stellate cell-induced liver inflammation and fibrosis in NASH
Anissa Anindya Widjaja, Brijesh Kumar Singh, Eleonora Adami…·Stuart A. Cook
This study identifies IL-11 as a key driver of HSC-to-myofibroblast transformation in NASH, showing that targeting IL-11 reduces fibrosis and inflammation in preclinical models.
280 citationstop 1%